John C. Byrd, a physician scientist who specializes in hematologic malignancies, was appointed director of UPMC Hillman Cancer Center.
Richard L. Schilsky has left his role as inaugural principal investigator of the American Society of Clinical Oncology-led Targeted Agent and Profiling Utilization Registry study after a decade of leadership.
Concert AI’s CancerLinQ initiative has received ASCO’s Recognized Quality Solution status—a recognition that positions the platform as a validated gateway for partnered oncology practices into ASCO’s flagship certification program.
Catheryn Yashar, chief medical officer and breast and gynecologic cancer radiation oncologist at UC San Diego Health, was appointed president-elect of the American Society for Radiation Oncology.
Motaz Qadan was named surgeon-in-chief for the Mass General Brigham Cancer Institute, effective Aug. 17.
Alice T. Shaw was named chair of the Department of Medical Oncology at Dana-Farber Cancer Institute.
Weizhou Zhang, a researcher in the fields of breast cancer and cancer immunotherapy, was appointed co-leader of the UF Health Cancer Center’s Mechanisms of Oncogenesis research program.
Julie BaumanRyan BurriNRG Oncology, an NCI National Clinical Trials Network group focused on multi-center clinical research, appointed Julie Bauman as deputy chair of the Community Oncology Research Program.
Kai Tsao was named system chief of solid tumor oncology, at the Northwell Cancer Institute.
The Sandra and Edward Meyer Cancer Center of Weill Cornell Medicine and NewYork- Presbyterian Hospital has appointed Laura Pinheiro to join Erica Phillips in co-leading the Center’s Office of Community Outreach and Engagement.
